Skip to main content
PLOS One logoLink to PLOS One
. 2021 Mar 15;16(3):e0242396. doi: 10.1371/journal.pone.0242396

Microbial population shift and metabolic characterization of silver diamine fluoride treatment failure on dental caries

Bidisha Paul 1, Maria A Sierra 1, Fangxi Xu 1, Yasmi O Crystal 2, Xin Li 1, Deepak Saxena 1,*, Ryan Richard Ruff 3,4,*
Editor: Ping Xu5
PMCID: PMC7959385  PMID: 33720954

Abstract

The objective of this pilot study was to describe the microbial profiles present in the plaque and saliva of children who continued to develop new carious lesions following treatment with silver diamine fluoride (“nonresponders”) compared to caries active, caries-free, and children immediately receiving SDF treatment for untreated caries in order to identify potential microbial differences that may relate to a re-incidence of caries. Saliva and plaque samples from infected and contralateral sites were obtained from twenty children who were either caries free, had active carious lesions, were caries active and received SDF treatment immediately before sampling, or had previously received SDF treatment and developed new caries. In total, 8,057,899 Illumina-generated sequence reads from 60 samples were obtained. Reads were processed using the Quantitative Insights Into Microbial Ecology pipeline. Group differences were assessed using Analysis of Variance Models and Tukey Honest Significant Differences. To identify significant taxa between treatment groups, Linear discriminant analysis Effect Size (LefSe) and Analysis of Differential Abundance Taking Sample Variation Into Account were used. Differential abundant analysis indicated that members of the Lachnospiraceae family were significantly enriched in non-responders and the genus Tannerella and species Granulicatella adiances were also highly abundant in this group. LefSe analysis between non-responders and SDF-treated groups revealed that genera Leptotrichia and Granulicatella were enriched in non-responders. We observed the highest abundance of phosphotransferase system and lowest abundance of lipopolysaccharide synthesis in non-responders. The microbiome in dental biofilms is responsible for initiation and progression of dental caries. SDF has been shown to be effective in arresting the progression carious lesions, in part due to its antimicrobial properties. Findings suggest that the differential abundance of select microbiota and specific pathway functioning in individuals that present with recurrent decay after SDF treatment may contribute to a potential failure of silver diamine fluoride to arrest dental caries. However, the short duration of sample collection following SDF application and the small sample size emphasize the need for further data and additional analysis.

Introduction

Dental caries is a multifactorial disease that occurs when a dysbiosis of the oral microbiome, fueled by frequent consumption fermentable carbohydrates, favors the proliferation of acidogenic and aciduric microorganisms in susceptible hosts [1]. Known common species that are associated with dental caries include Streptococcus mutans, Streptococcus sobrinus, and Veillonella parvula [2]. The increased prevalence of this taxa leads to a high abundance of organic acids in contact with tooth surfaces, potentially causing the demineralization of enamel crystals [3]. Over time, sustained mineral loss results in the cavitation of enamel and dentinal tissues which if untreated can progress into the pulp of the tooth causing infection, pain, and eventually tooth loss [4,5].

Epidemiologically, caries is the most prevalent childhood disease worldwide [6,7]. Untreated dental caries affects more than 20% of elementary school-aged children in the United States, and over 50% of children have had caries experience [8,9]. For low-income and minority children, caries incidences can exceed 70% and the prevalence of untreated caries is over 30%, which negatively affects the quality of life of this vulnerable population. Children most at risk for oral diseases face profound health inequalities and often lack access to oral health services [1014]. To address this unmet need, several clinical trials on the pragmatic use of non-surgical methods for caries management are currently in progress [15,16].

Silver diamine fluoride (SDF) is a novel therapy for non-surgical caries management in the United States [17] consisting of a clear liquid that is easily and painlessly applied to caries lesions to arrest their progression. A 38% concentrated SDF application consists of 24–27% silver, 7.5–11% ammonia, and 5–6% fluoride, combining the antibacterial action of silver with the remineralization of fluoride in an alkaline solution that is unfavorable to collagen degradation and has been shown to act as a bactericidal agent to cariogenic bacteria, specifically Streptococcus mutans [18]. In vitro studies using single or multi-species biofilm models have shown that silver interacts with bacterial cell membranes and bacterial enzymes to inhibit bacterial growth [19]; however, these antibacterial actions have not yet been confirmed with in-vivo studies. Clinical trials [20] report arrest rates of approximately 80% on primary teeth, with variation in range depending on tooth location, size of the cavity, and presence of plaque. Thus, while effective in the majority of cases, there are lesions for which progression will not be halted by the application of SDF. This treatment failure could be attributed in part to the specific oral microbiome in patients who do not respond to treatment (“non-responders”).

The mechanisms underlying arrest failure or refractory growth of caries initially arrested by SDF remains unknown. Our main objective in this study is to analyze the microbial profiles present in the plaque and saliva of children who have developed new carious lesions following SDF treatment. Non-responsive children were compared with those with active caries, those with active caries treated with SDF, and those who were caries-free to identify key taxa that may contribute to a lack of response to SDF therapy.

Methods

Study design

This cross-sectional observational pilot study was approved by the NYU School of Medicine IRB (i19-00692). Children attending the pediatric dentistry clinic at the NYU College of Dentistry for periodic preventive or restorative appointments who were between 6 and 13 years old, healthy, and fit study group criteria were approached to participate. Excluded subjects were those who were currently or had been on antibiotic therapy in the previous two months, reported systemic disease in the previous two months, or exhibited uncooperative behaviors that prohibited sample collection.

Consent was collected from the parents of 20 children and child assent was obtained prior to enrollment. Children were divided into four groups of five subjects each according to their clinical profile at enrollment: caries-free, consisting of those who did not present with dental caries; caries-active, those who had active untreated dental caries; SDF-treated, those who presented with open cavities treated with SDF immediately after enrollment; and non-responders, those who had received SDF for dental caries in the past six months but presented with new active caries at enrollment. Study subjects were recruited during their routine scheduled appointments and samples were collected at the same visit. Data on the time of the subjects’ last meal, the last toothbrushing or toothpaste exposure, and time of day were recorded, as was the date of the previous SDF application for the non-responder group. Age, sex, ethnicity, and caries status were also recorded on de-identified forms.

Untreated new and reoccurring dental caries were defined by subjects presenting with visible cavitated lesions corresponding to an International Caries Detection and Assessment System (ICDAS) score of 3 or higher. Patients received SDF during the enrollment visit if they presented with visual cavitated lesions consisting of an ICDAS score of 4 or higher.

SDF application

Oral examinations and subsequent SDF application were performed by a single clinician (YC). All treated areas were similar, as patients were older than five and under continuous care at the New York University College of Dentistry clinic. All subjects with caries had small lesions into enamel and dentin and confined to a single surface only. Infection was treated using a standardized amount of SDF (single drop); an average drop of SDF measuring 32.5 mL consists of approximately 1.64 to 1.75 mg of fluoride and 8.08 to 8.71 mg of silver [21].

Sample collection

Unstimulated saliva samples and two supragingival plaque samples were collected from participants in a single visit by a single calibrated clinical investigator following a set protocol. For unstimulated saliva, children were instructed to place a 10 ml collection tube under their lip and drool into it until approximately 1 ml of saliva was collected. For plaque samples, a sterile curette was used to collect plaque from specific tooth sites and then placed in a vial with TE buffer, avoiding prolonged air exposure (< 10 seconds). Caries-free children had plaque collected from buccal sites on both sides of a maxillary molar. Children with active decay had plaque collected from the same surface as the active caries lesion as well as the contralateral tooth. Those who had been treated with SDF at study visit had plaque collected from the treated carious surface and the contralateral side within 10 minutes following SDF application. Participants previously treated with SDF presenting with active decay provided a plaque sample from the previously treated tooth and the contralateral side. Saliva samples were collected first, followed by the plaque samples. The total collection time was less than 4 minutes with variation only in the time it took each child to collect 1 ml of saliva. Samples were immediately transported to a freezing unit and stored at -80°C until ready for further analysis. The total time from collection to storage was less than 5 minutes for each set of samples.

Total bacterial DNA extraction and 16S rRNA amplicon sequencing

Total bacterial genomic DNA was purified from 20 saliva samples and 40 sub-gingival plaque samples using the QIAamp PowerFecal Kit (Qiagen). Extracted DNA was then quantified for concentration and purity initially by NanoDrop 2000 spectrophotometer (Thermo Scientific), and further verified fluorometrically by Quant-iT PicoGreen dsDNA Assay Kit (Invitrogen) using the SpectraMax M5 microplate reader (Molecular Devices), then stored at -20°C until further analysis. Library preparation involved amplifying the V3-V4 hypervariable region of the 16S rRNA gene in the saliva and plaque samples in accordance with the Illumina 16S metagenomics protocol (Part #15044223 Rev. B). The DNA samples were diluted or concentrated to 10 ng/μL. They were further amplified by performing PCR using 2× KAPA HiFi HotStart ReadyMix DNA polymerase (KapaBiosystems) and primer set 341F (5′-CCTACGGGNGGCWGCAG-3′) and 805R (5′-GACTACHVGGGTATCTAATCC-3′), each with overhang adapter sequences (IDT). PCR conditions were 95°C (3 minutes), with 25 cycles of 95°C (30 seconds), 55°C (30 seconds), 72°C (30 seconds), and a final extension at 72°C (5 minutes). The resultant amplicons were purified using AMPure XP beads. A second PCR was performed with dual indices from the Nextera XT Index Kit (Illumina) and 2× KAPA HiFi HotStart ReadyMix DNA polymerase. Amplification was performed at 95°C (3 minutes), with 8 cycles of 95°C (30 seconds), 55°C (30 seconds), 72°C (30 seconds), and a final extension at 72°C (5 minutes). After purification with AMPure XP beads, the samples were quantified again using the PicoGreen assay, and their size was confirmed by agarose gel electrophoresis. Equimolar amounts of each sample were pooled, denatured, and sequenced using the 300-bp paired-end sequencing protocol and Illumina’s MiSeq Reagent Kit V3 (600 cycles).

Analyses of sequence data

In total, 8,057,899 Illumina-generated sequence reads from 60 samples were obtained. Reads were processed using the Quantitative Insights Into Microbial Ecology pipeline v2.0 (QIIME2) with the following parameters: demultiplexed FASTQs from Illumina were imported with qiime tools import—type SampleData[PairedEndSequencesWithQuality]—input-format CasavaOneEightSingleLanePerSampleDirFmt; DADA2 was used to denoised reads with qiime dada2 denoise-paired—p-trunc-len-f 0—p-trunc-len-r 200; A phylogenetic tree was created with FastTree using MAFFT alignment with qiime phylogeny align-to-tree-mafft-fasttree; For taxonomic classification, the HOMD database [22] was used to train the Naïve Bayes classifier to the 16SrRNA v4-v5 region with the primers 341F 5’–CCTACGGGNGGCWGCAG–3’ and 806R 3’–GACTACHVGGGTATCTAATCC–5’ using qiime feature-classifier extract-reads—p-trunc-len 200.

In total, 3,963 amplicon sequence variants (ASVs) were generated. Diversity analyses, comparisons, and plots were generated in R. Samples collected from saliva and plaque were grouped into SDF-treated, non-responders, caries-free, and caries-active study groups. Alpha diversity indices were calculated using Phyloseq v.1.30 [23]. Group differences were assessed using analysis of variance models (aov) and Tukey’s honest significant differences test (TukeyHSD) via the Stats package (v3.6.2) with statistical significance set at p < 0.05. To compare microbial composition between groups, a principal component analysis (PCA) was generated based on a Unifrac distant matrix, and significance between clusters was calculated with permutational multivariate analysis of variance (adonis) using distance matrices (vegan package v2.5.6).

To identify significant taxa between treatment groups, we used Linear discriminant analysis Effect Size (LefSe, Galaxy/Hutlab) and analysis of differential abundance taking sample variation into account (ALDEx2) [24,25].

PICRUSt analysis

Phylogenetic Investigation of Communities by Reconstruction of Unobserved States (PICRUSt) was used to predict metagenome functional content from marker genes (16S rRNA). Illumina-generated sequences reads were processed using QIIME2 with the following parameters: demultiplexed FASTQs from Illumina were imported with qiime tools import—type SampleData[PairedEndSequencesWithQuality]—input-format CasavaOneEightSingleLanePerSampleDirFmt; paired ends sequences were joined with qiime vsearch join-pairs; and then filtered based on the quality score with qiime quality-filter q-score-joined. Filtered sequences were dereplicated using qiime vsearch dereplicate-sequences. Dereplicated sequences were then clustered into OTUs using the closed reference OTU picking method. Clustering was performed at 97% identity against the Greengenes v.13.5 97% OTUs reference database with qiime vsearch cluster-features-closed-reference. The exported OTU file was then uploaded to Galaxy/Hutlab for PICRUSt analysis: the OTU table was first corrected for multiple 16S copy number, the normalized OTU table was processed by the ’Predict Metagenome’ step to obtain metagenome predictions, and a PICRUSt prediction table at KEGG Pathway Hierarchy Level 3 was produced. PCA analysis, the relative abundance of specific pathways comparisons between treatments, and plots were generated in R.

Results

Saliva and plaque samples carry different microbial communities

Most alpha diversity indices did not differ significantly among the four groups. α-diversity measures in saliva samples indicated that (Fig 1A) caries-free and SDF-treated subjects had markedly increased richness compared with caries-active and non-responders based on observed taxa and Simpson indices and increased diversity evenness based on the Shannon index.

Fig 1. Microbial diversity varies across saliva and plaque.

Fig 1

Diversity and richness values for (A) saliva samples, (B) plaque infected and (C) contralateral plaque, per treatment group measured by the Observed number of taxa, and the Shannon and Simpson indices. Multiple comparisons of richness and diversity measures were performed by Tukey’s range test with p values of < 0.05 considered to be statistically significant. Asterisks indicate significant differences between Observed number of taxa in SDF and Non-responders in the contralateral plaque (p = 0.049). (D) Principal Coordinates Analysis (PCoA) based on the UniFrac distance matrix comparing saliva and plaque samples, and (E) within each treatment group. Comparisons of plaque infected and contralateral site in (F) caries active, (G) non-responders and (H) SDF treated group. (I) Principal Coordinates Analysis (PCoA) based on the UniFrac distance matrix comparing plaque samples types iin each treatment group, (J) comparing caries-active group with caries-free group, and (K) non-responders with SDF treated group.

In plaque-infected samples, alpha diversity indices were slightly higher in the SDF-treated group based on the Shannon and Simpson diversity indices (Fig 1B). In contralateral plaque, the number of observed taxa in non-responders was lower compared to other groups especially when compared to SDF-treated subjects (p = 0.049) (Fig 1C).

Distinct microbial communities in saliva and plaque were confirmed by PCA generated using UniFrac distance metrics (p = 0.0009) (Fig 1D). Each plaque and saliva group also revealed significantly different clusters in the four treatment groups: caries-active, caries-free, non-responders, and SDF-treated (Fig 1E). Alpha diversity within plaque samples was measured by the number of observed taxa and the Shannon and Simpson diversity indices. Contralateral and infected sites were compared in caries-active (Fig 1F), non-responders (Fig 1G), and SDF-treated (Fig 1H) subjects. Interestingly, the infected site in non-responders had a significantly higher number of observed taxa than their contralateral site (p = 0.029). Contralateral and infected sites had overlapping microbial communities in all four treatment groups (Fig 1I). When comparing treatment groups in plaque samples, caries-active and caries-free groups were significantly different (p = 0.003) (Fig 1J); however, no distinct clusters were found when comparing non-responders and SDF-treated subjects (Fig 1K).

Specific taxa might be linked to non-responsive patients

Taxonomic assignment identified the predominance of phylum Saccharibacteria, Firmicutes Bacteroidetes, Proteobacteria, Fusobacteria, and Actinobacteria in plaque-infected samples among all treatments (Fig 2A). Fig 2B depicts the top 40 genera of bacteria in the plaque-infected samples clustered according to the treatment group. Genera commonly of interest in pediatric dental caries research (i.e., Streptococcus, Prevotella, Capnocytophaga, Leptotrichia) were found to be highly abundant. At the species level, non-responders seem to have a higher abundance of Prevotella melaninogenica, Veillonella denticariosi, and Rothia dentocariosa, although no statistically significant differences were observed among the groups. Of note, the dental caries pathogen Streptococcus mutans was more abundant in the non-responder and SDF-treated groups compared with the other treatment groups.

Fig 2. Microbial shifts across treatment groups.

Fig 2

(A) Heatmap of the relative abundance of taxa present in the infected plaque at phylum level Log10 transformed. (B) Heatmap of the relative abundance of the top 40 most abundant taxa in the infected plaque at genus level Log10 transformed. Significant genera (LEFse) between non-responders and SDF-treated (C) and caries-free (D) groups. Taxa found significantly different in abundance in the four treatment groups of the infected plaque, corresponding to (E) Lachnospiraceae, (F) Tannerella, and (G) Granulicatella adiacens.

LefSe analysis between non-responders and SDF-treated groups in plaque infected samples revealed that the genera Leptotrichia and Granulicatella were enriched in non-responders (Fig 2C) while the comparison between non-responders and caries-free showed Saccharibacteria to be enriched in the caries-free group (Fig 2D). Analyses of differential abundance (ALDEx2) indicated that members of the Lachnospiraceae family were significantly enriched in non-responders (Fig 2E) and the genus Tannerella (Fig 2F) and species Granulicatella adiances (Fig 2G) were also highly abundant in this group. Other group comparisons were not significant.

Predicted bacterial gene function pathways differential response in treatment groups

Principal Component Analysis (PCA) plot (Fig 3A) does not show any significant difference among groups in plaque infected samples. In PICRUst analyses, we tested pathways that may be relevant in oral microbiome studies of dental caries, such as those related to carbohydrate metabolism, environmental information processing, and human diseases (Table 1). SDF group had lowest abundance of ABC transporters and amino carbohydrate and nucleotide carbohydrate metabolism pathways while having high abundance of bacterial invasion of epithelial cells (Fig 3B). In the environment information processing-membrane transport pathway, the phosphotransferase system (PTS) was more abundant in non-responders. Lipopolysaccharide synthesis was highest in caries-free subjects and lowest in SDF-treated group. However, there were no statistically significant differences observed among the groups in any of the pathways.

Fig 3. PCA plot for pathways by group (A); Boxplots for relative abundance of select pathways (B).

Fig 3

Table 1. KEGG pathways in oral microbiome studies.

Pathways (Level 1,2 and 3) Importance in oral studies
Metabolism; Carbohydrate Metabolism; Amino carbohydrate and nucleotide carbohydrate metabolism Amino carbohydrates are the major components of cell envelopes of fungi and bacteria and they are also important constituents of glycoproteins across all domains of life [26]
Environmental Information Processing; Membrane Transport; ABC transporters Maltose transporter (MalEFGK2) predominant in anaerobes with substrate-level phosphorylation [27]
Environmental Information Processing; Membrane Transport; Phosphotransferase system (PTS) Glucose transporter (IIAGlc/IICBGlc) Mannose/glucose transporter (IIABMan/IICMan/IIDMan) [27]
Human Diseases; Infectious Diseases; Bacterial invasion of epithelial cells Oral pathogenic bacteria adhere to and invade both monolayers and multilayers of primary gingival epithelial cells (GEC) [28].
Environmental Information Processing; Signaling Molecules and Interaction; Bacterial toxins Periodontal pathogens release endotoxin that interacts with the tissues and the host’s response [29].
Metabolism; Glycan Biosynthesis and Metabolism; Lipopolysaccharide(LPS) biosynthesis LPS comprising the outer surface of Gram-negative bacteria. High levels of lipid A from P. gingivalis indicative of inflammation in periodontal tissues [30].

Discussion

Dental caries remains a significant and persistent oral health malady in children. The microbiome in dental biofilms is responsible for the initiation and progression of dental caries. Studies suggest that SDF is effective in arresting the progression of caries lesions due to the antimicrobial properties of silver and fluoride, the hardening of the lesion due to the re-mineralizing effects of fluoride, and the reduction of collagen degradation through inhibition of specific enzymes (metalloproteinases and cathepsins) [31]. However, despite a high efficacy rate, some children or lesions remain resistant to its therapeutic effects. In the present study, we assessed the microbial composition of saliva and plaque of four treatment groups—caries-active, caries-free, non-responders, and SDF-treated—and identified bacterial species that are significantly enriched in non-responders.

Overall, there were distinct microbiome profiles among the saliva and plaque samples, supporting results from previous studies that implicate specific microorganisms in the cariogenic process [32,33]. Alpha diversity indices indicated that there were no significant differences across treatment groups, similar to research showing no differences in diversity comparing caries-free and caries-active children [34], however, samples from infected sites had more richness and diversity than contralateral site and saliva. Though not significant, SDF-treated subjects had the highest richness. Comparisons between treatment groups revealed a distinct microbiota of plaque and saliva samples, but as expected, there were no differences in microbial composition between infected and contralateral plaque sites. Interestingly, the non-responder group had a higher number of observed taxa in the infected site compared with its contralateral side.

Although PCA did not reveal any significant differences among the four groups, there was a significant differential abundance of bacteria at the genus and species level detected with ALDEx2. The genus Granulicatella was found to be higher in non-responders when compared with the SDF-treated group. Granulicatella belongs to the nutritionally variant Streptococci (NVS) group, a group of fastidious, Gram-positive bacteria. NVS require an L-cysteine- or pyridoxal-supplemented medium to support growth and can be distinguished from other streptococci by the presence of cell wall chromophore as well as its distinct enzymatic and serological characteristics [35]. Granulicatella is involved in microbial coaggregation especially with F. nucleatum which influences the development of complex multi-species biofilm [36]. Since non-responders possess a high abundance of this bacteria, its acidic products of metabolism along with its propensity to aggregate with other colonizers may contribute to resistance against the anti-bacterial properties of SDF. The species Granulicatella adiacens that was significantly higher in non-responders is frequently found in dental plaque, endodontic infection, and dental abscesses, and is also associated with other serious infections [37]. By comparing non-responders and SDF-treated subjects using LEfSe, in addition to Granulicatella, the genus Leptotrichia was more abundant in the plaque-infected site. Leptotrichia is Gram-negative, bacilli, anaerobic, non-spore-forming, saccharolytic, and primarily reside in the oral cavity [38]. Previous studies have shown an association between dental caries and Leptotrichia and it likely plays an important role in the caries development process [3941]. They are non-motile and ferment carbohydrates to produce various organic acids, including lactic acid, and traces of acetic, formic, or succinic acid, depending on the substrates and species. Leptotrichia thus possesses characteristics similar to Streptococcus mutans as it ferments a large variety of mono- and disaccharides into lactic acid [42]. The acid produced by the bacteria may directly contribute to the demineralization of the tooth enamel, or may attract other aciduric bacteria that contribute to the caries process.

We also report a high abundance of the genus Tannerella in non-responders. The most prominent species of the group, Tannerella forsythia, is a member of the “Red Complex” group [43]. T. Forsythia is the only member of the genus that can be cultured and forms a synergistic biofilm with F. nucleatum [44]. The antibacterial activity of silver ions in SDF is lower in dual-species biofilms compared with single-species biofilms [31]. The abundance of Tannerella in non-responders may reflect SDF’s inability to combat dual-species biofilm formation. However, the presence of the genus Tannerella merits more study.

Analysis of predicted microbiota functioning revealed that the phosphotransferase system (PTS) was higher in non-responders. The PTS performs catalytic and regulatory functions in bacteria. It acts as a catalyst for the transportation and phosphorylation of a variety of carbohydrates and carbohydrate derivatives and also regulates the virulence of certain pathogens [45]. Bacteria belonging to genus Tannerella, Leptotrichia, and Granulicatella, which are highly abundant in non-responders, could be utilizing the PTS system to uptake carbohydrates for their metabolism or the expression of their virulence genes and, thus, exhibited an increase in this function.

16S rRNA gene amplicon sequencing captures broad shifts in community diversity over time, but with limited resolution and lower sensitivity compared to metagenomic shotgun sequencing. Our use of the PICRUSt package to predict metagenome functional content from 16S rRNA extends our analysis. Though bias may have been introduced due to varying 16S rRNA PCR amplification frequencies, sequencing errors due to PCR amplification were mitigated by removing mismatches from primers, and denoising and trimming reads with low quality scores during sequencing analyses. Further, the use of a single application of SDF, a relatively short duration between SDF application and sample collection, and the small sample size per group limit generalizability to the greater responder and non-responder populations. As this was a pilot study, access to subjects and corresponding specimens was limited to a single observation. Though identifying the DNA of present bacteria does not elucidate their viability, we elected to investigate the potential immediate measurable effect of therapy to support future study.

Our results are consistent with other research, as no overall significant microbial changes were observed between subjects that had active caries following SDF application and those with caries arrested by SDF [46]. SDF may need to be repeatedly applied at specific intervals to exert its desired effects on the recolonizing bacteria. However, the primary objective of this study was to explore the microbial composition of non-responders that seem to resist the potent antibacterial properties of SDF and how they differ from other groups of patients. The bacteria abundant in non-responders, including Tannerella, Granulicatella, and Leptotrichia, may play a role in a child’s lack of response to SDF treatment. In-depth studies of non-responders’ biofilm formation mechanisms would likely provide insight into how these organisms evade the antibacterial properties of SDF. Overall, the increased utilization of SDF and other non-surgical interventions for caries in community settings [15,16] can reduce oral health inequities [47], but a lack of treatment response may leave a susceptible portion of the population vulnerable to disease progression. Additional study is needed to support a deeper understanding of the mechanistic actions underlying the non-responsiveness to SDF; future planned research will follow subjects longitudinally with variable rates of follow-up post-SDF application.

Data Availability

BIOM files generated with QIIME2 and scripts used to generate figures are available on GitHub (https://github.com/mariaasierra/Dental_Caries).

Funding Statement

This study was funded in part by awards from the New York University Grant Support Initiative (#RA633, Ruff PI) and the National Institute of Dental and Craniofacial Research (#R56DE028933, Ruff and Saxena, PIs). The content is solely the responsibility of the authors and does not necessarily reflect the official views of the National Institutes of Health, New York University, the New York University College of Dentistry, or the New York University School of Medicine.

References

  • 1.Dzidic M., et al., Oral microbiome development during childhood: an ecological succession influenced by postnatal factors and associated with tooth decay. The ISME Journal, 2018. 12(9): p. 2292–2306. 10.1038/s41396-018-0204-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Gross E.L., et al., Beyond Streptococcus mutans: Dental Caries Onset Linked to Multiple Species by 16S rRNA Community Analysis, in PLoS One. 2012. 10.1371/journal.pone.0047722 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Featherstone J. and Chaffee B., The Evidence for Caries Management by Risk Assessment (CAMBRA®), in Adv Dent Res. 2018. p. 9–14. 10.1177/0022034517736500 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.NK F., et al., Clinical Consequences of Untreated Dental Caries and Toothache in Preschool Children. Pediatric dentistry, 2014. 36(5). [PubMed] [Google Scholar]
  • 5.Meyer F. and Enax J., Early Childhood Caries: Epidemiology, Aetiology, and Prevention. International Journal of Dentistry, 2018. 2018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Marcenes W., et al., Global burden of oral conditions in 1990–2010: a systematic analysis. Journal of dental research, 2013. 92(7): p. 592–7. 10.1177/0022034513490168 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Kassebaum N.J., et al., Global, Regional, and National Prevalence, Incidence, and Disability-Adjusted Life Years for Oral Conditions for 195 Countries, 1990–2015: A Systematic Analysis for the Global Burden of Diseases, Injuries, and Risk Factors. Journal of Dental Research, 2017. 96(4): p. 380–387. 10.1177/0022034517693566 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Dye B., Li X., and Thornton-Evans G., Oral health disparities as determined by selected Healthy People 2020 Oral Health objectives for the United States, 2009–2010. NCHS Data Brief, 2012. 104: p. 1–8. [PubMed] [Google Scholar]
  • 9.Dye B.A., et al., Dental caries and sealant prevalence in children and adolescents in the United States, 2011–2012. NCHS Data Brief, 2015(191): p. 1–8. [PubMed] [Google Scholar]
  • 10.Treadwell H.M., The Nation’s Oral Health Inequities: Who Cares. Am J Public Health, 2017. 107(S1): p. S5. 10.2105/AJPH.2017.303957 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Griffin S.O., et al., Vital Signs: Dental Sealant Use and Untreated Tooth Decay Among U.S. School-Aged Children. MMWR Morb Mortal Wkly Rep, 2016. 65(41): p. 1141–1145. 10.15585/mmwr.mm6541e1 [DOI] [PubMed] [Google Scholar]
  • 12.Dye B.A. and Thornton-Evans G., Trends in oral health by poverty status as measured by Healthy People 2010 objectives. Public health reports (Washington, D.C.: 1974), 2010. 125(6): p. 817–30. 10.1177/003335491012500609 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.A national call to action to promote oral health, P.H.S. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, and the National Institutes of Health, National Institute of Dental and Craniofacial Research, Editor. May 2003, U.S. Department of Health and Human Services: Rockville, MD.
  • 14.Griffin S.O., et al., Use of dental care and effective preventive services in preventing tooth decay among U.S. Children and adolescents—Medical Expenditure Panel Survey, United States, 2003–2009 and National Health and Nutrition Examination Survey, United States, 2005–2010. MMWR Surveill Summ, 2014. 63 Suppl 2: p. 54–60. [PubMed] [Google Scholar]
  • 15.Ruff R.R. and Niederman R., Silver diamine fluoride versus therapeutic sealants for the arrest and prevention of dental caries in low-income minority children: study protocol for a cluster randomized controlled trial. Trials, 2018. 19(1): p. 523. 10.1186/s13063-018-2891-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Ruff R.R. and Niederman R., Comparative effectiveness of treatments to prevent dental caries given to rural children in school-based settings: protocol for a cluster randomised controlled trial. BMJ Open, 2018. 8(4): p. e022646. 10.1136/bmjopen-2018-022646 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.C. YO and N. R, Silver Diamine Fluoride Treatment Considerations in Children’s Caries Management. Pediatric dentistry, 2016. 38(7). [PMC free article] [PubMed] [Google Scholar]
  • 18.Zhao I.S., et al., Mechanisms of silver diamine fluoride on arresting caries: a literature review. Int Dent J, 2018. 68(2): p. 67–76. 10.1111/idj.12320 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.M. ML, L. ECM, and C. CH, Arresting Dentine Caries With Silver Diamine Fluoride: What’s Behind It? Journal of dental research, 2018. 97(7). [DOI] [PubMed] [Google Scholar]
  • 20.Gao S.S., et al., Clinical Trials of Silver Diamine Fluoride in Arresting Caries among Children: A Systematic Review. JDR Clin Trans Res, 2016. 1(3): p. 201–210. 10.1177/2380084416661474 [DOI] [PubMed] [Google Scholar]
  • 21.Crystal Y.O., et al., Silver and fluoride content and short-term stability of 38% silver diamine fluoride. J Am Dent Assoc, 2019. 150(2): p. 140–146. 10.1016/j.adaj.2018.10.016 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Escapa I.F., et al., New Insights into Human Nostril Microbiome from the Expanded Human Oral Microbiome Database (eHOMD): a Resource for the Microbiome of the Human Aerodigestive Tract. mSystems, 2018. 3(6). 10.1128/mSystems.00187-18 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.McMurdie P.J. and Holmes S., phyloseq: an R package for reproducible interactive analysis and graphics of microbiome census data. PLoS One, 2013. 8(4): p. e61217. 10.1371/journal.pone.0061217 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Fernandes A.D., et al., ANOVA-like differential expression (ALDEx) analysis for mixed population RNA-Seq. PLoS One, 2013. 8(7): p. e67019. 10.1371/journal.pone.0067019 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Gloor G.B., et al., It’s all relative: analyzing microbiome data as compositions. Ann Epidemiol, 2016. 26(5): p. 322–9. 10.1016/j.annepidem.2016.03.003 [DOI] [PubMed] [Google Scholar]
  • 26.Zeng L., Farivar T., and Burne R.A., Amino Sugars Enhance the Competitiveness of Beneficial Commensals with Streptococcus mutans through Multiple Mechanisms. Applied and Environmental Microbiology, 2016. 82(12): p. 3671–3682. 10.1128/AEM.00637-16 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Jeckelmann J.-M. and Erni B., Transporters of glucose and other carbohydrates in bacteria. Pflugers Archiv: European journal of physiology, 2020. [DOI] [PubMed] [Google Scholar]
  • 28.Hanel A.N., et al., Effects of Oral Commensal Streptococci on Porphyromonas gingivalis Invasion into Oral Epithelial Cells. Dentistry Journal, 2020. 8(2): p. 39. 10.3390/dj8020039 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Johansson A. and Dahlén G., Bacterial virulence factors that contribute to periodontal pathogenesis, in Pathogenesis of Periodontal Diseases. 2018, Springer. p. 31–49. [Google Scholar]
  • 30.Duran-Pinedo A.E., et al., Community-wide transcriptome of the oral microbiome in subjects with and without periodontitis. The ISME Journal, 2014. 8(8): p. 1659–1672. 10.1038/ismej.2014.23 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Mei M.L., et al., Caries arresting effect of silver diamine fluoride on dentine carious lesion with S. mutans and L. acidophilus dual-species cariogenic biofilm. 2013. 18(6): p. e824. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Struzycka I., The oral microbiome in dental caries. Pol J Microbiol, 2014. 63(2): p. 127–35. [PubMed] [Google Scholar]
  • 33.Mira A., Oral Microbiome Studies: Potential Diagnostic and Therapeutic Implications. Adv Dent Res, 2018. 29(1): p. 71–77. 10.1177/0022034517737024 [DOI] [PubMed] [Google Scholar]
  • 34.Jiang S., et al., Salivary Microbiome Diversity in Caries-Free and Caries-Affected Children. Int J Mol Sci, 2016. 17(12). 10.3390/ijms17121978 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Alberti M.O., et al., Antimicrobial susceptibilities of Abiotrophia defectiva, Granulicatella adiacens, and Granulicatella elegans. 2016. 60(3): p. 1411–1420. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Karched M., Bhardwaj R.G., and Asikainen S.E., Coaggregation and biofilm growth of Granulicatella spp. with Fusobacterium nucleatum and Aggregatibacter actinomycetemcomitans. BMC Microbiology, 2015. 15(1): p. 114. 10.1186/s12866-015-0439-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Khalili H., Sisakhtpour R., and Abdollahzadeh S.J.I.P., Identification of biofilm producing bacterial species causing dental caries and their sensitivity to zoocin A and clove hydroalcoholic extract. 2018. 4(2): p. e27–e27. [Google Scholar]
  • 38.Le Bars P., et al., The oral cavity microbiota: between health, oral disease, and cancers of the aerodigestive tract. 2017. 63(6): p. 475–492. [DOI] [PubMed] [Google Scholar]
  • 39.Luo A., et al., Microbial profiles in saliva from children with and without caries in mixed dentition. 2012. 18(6): p. 595–601. [DOI] [PubMed] [Google Scholar]
  • 40.Ling Z., et al., Analysis of oral microbiota in children with dental caries by PCR-DGGE and barcoded pyrosequencing. 2010. 60(3): p. 677–690. [DOI] [PubMed] [Google Scholar]
  • 41.Li F., et al., Establishment and development of oral microflora in 12–24 month-old toddlers monitored by high-throughput sequencing. 2018. 8: p. 422. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Eribe E.R.K. and Olsen I., Leptotrichia species in human infections II. Journal of oral microbiology, 2017. 9(1): p. 1368848–1368848. 10.1080/20002297.2017.1368848 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Mohanty R., et al., Red complex: Polymicrobial conglomerate in oral flora: A review. 2019. 8(11): p. 3480. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Sharma A., Virulence mechanisms of Tannerella forsythia. Periodontology 2000, 2010. 54(1): p. 106–116. 10.1111/j.1600-0757.2009.00332.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Deutscher J., et al., The Bacterial Phosphoenolpyruvate:Carbohydrate Phosphotransferase System: Regulation by Protein Phosphorylation and Phosphorylation-Dependent Protein-Protein Interactions. Microbiology and Molecular Biology Reviews, 2014. 78(2): p. 231. 10.1128/MMBR.00001-14 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Mei M.L., et al., Effect of silver diamine fluoride on plaque microbiome in children. 2020: p. 100016. [DOI] [PubMed] [Google Scholar]
  • 47.Ruff R.R. and Niederman R., Comparative effectiveness of school-based caries prevention: a prospective cohort study. BMC Oral Health, 2018. 18(1): p. 53. 10.1186/s12903-018-0514-6 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Ping Xu

8 Dec 2020

PONE-D-20-34812

Microbial population shift and metabolic characterization of silver diamine fluoride treatment failure on dental caries

PLOS ONE

Dear Dr. Ryan Richard Ruff,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please respond carefully to the reviewer’s comments point by point, especially the rationale for the small sample size and short-term treatment.

Please submit your revised manuscript by Jan 18 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Ping Xu

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please ensure that the Limitations of the study, such as the y short duration between sample collection and SDF application and the sample size, are mentioned in the Abstract.

3. Thank you for stating the following in the Funding Section of your manuscript:

"This study was funded in part by an award from the New York University Grant Support Initiative

(#RA633, Ru PI) and the National Institute of Dental and Craniofacial Research (#R56DE028933,

Ru and Saxena, PIs). The content is solely the responsibility of the authors and does not necessarily

re

ect the ocial views of the National Institutes of Health, New York University, the New

York University College of Dentistry, or the New York University School of Medicine."

We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form.

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows:

"The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: No

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Please address the following issues:

In the last section of the Introduction, remove metabolites from the text since this was not determined.

Throughout the text ensure that species names are italicized and Gram is written with a capital G.

If available provide more details of the SDF application among the study subjects. Was it applied by the same clinic/person? was a similar size area treated?

Discuss the limitations of the study including the small sample size, problems of 16S sRNA amplification bias.

Change sugar throughout the text to carbohydrate.

Reviewer #2: This manuscript examines the response of oral caries flora to treatment with silver diamine fluoride (SDF), a therapy used for non-surgical caries management in the US. Multiple in vitro studies have shown that SDF inhibits bacterial cell growth through interaction with bacterial cell membranes and enzymes. A primary goal of this study is to examine the efficacy of SDF in a cohort of 20 children 6-13 years of age, and identify the oral bacteria that contribute to a non-responder phenotype, in which the bacteria are resistant to or survive treatment with SDF and have low treatment efficacy. The primary limitations of the study include the small sample size and study design.

Comments:

1. The sample size is small, with 5 children in each of 4 separate treatment groups. The authors do clearly state that this is a pilot study, but do not sufficiently emphasize this limitation when drawing their conclusions in the results and discussion.

2. Is SDF bacteriostatic or bacteriocidal? This is a key, but unaddressed point, in the paper. Why would a bacteriostatic agent be an effective therapeutic?

3. In group 3, the authors sample plaque from surface of a tooth with open caries within 10 minutes after application of SDF. A reasonable rationale for this short time period between SDF application and plaque sampling is needed. An important aspect that the authors do not consider is viability of bacteria on the tooth surface. Taxonomic identification by 166 rRNA amplicon sequencing relies only on the presence of bacterial genomic DNA. It does not access viability of bacteria at that site.

4. The accepted term is 16S rRNA amplicon sequencing.

5. The print (text figure labels) in Figures 1-3 is small and will be very difficult to read when the figures are reduced for publication.

6. It is not clear what Fig 3 (PiCrust) contributes to the paper. None of the identified pathways are statistically significant and no meaningful conclusions can be drawn from this analysis.

7. The identification of Granulicatella, Leptotrrichia, and Tannerella in the non-responders is interesting, with a plausible biological basis of their roles in caries presented in the discussion.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2021 Mar 15;16(3):e0242396. doi: 10.1371/journal.pone.0242396.r002

Author response to Decision Letter 0


1 Jan 2021

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

Thank you for your assistance, we have updated the manuscript to align with the listed style requirements.

2. Please ensure that the Limitations of the study, such as the y short duration between sample collection and SDF application and the sample size, are mentioned in the Abstract.

We have added these limitations to the revised Abstract as appropriate.

3. Thank you for stating the following in the Funding Section of your manuscript:

"This study was funded in part by an award from the New York University Grant Support Initiative

(#RA633, Ru PI) and the National Institute of Dental and Craniofacial Research (#R56DE028933,

Ru and Saxena, PIs). The content is solely the responsibility of the authors and does not necessarily

re

ect the ocial views of the National Institutes of Health, New York University, the New

York University College of Dentistry, or the New York University School of Medicine."

We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form.

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows:

"The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

We have added the missing funder to the list on the online submission system and removed any funding language from the manuscript. As well, the cover letter is updated as instructed (I could not find the specific funding statement online, only the place to upload the funder information).

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

We sincerely thank the two reviewers who graciously offered their time to review our paper and provide feedback. We address each comment as listed below and provide our responses.

Reviewer #1: Please address the following issues:

In the last section of the Introduction, remove metabolites from the text since this was not determined.

This has been removed

Throughout the text ensure that species names are italicized and Gram is written with a capital G.

This has been checked and updated.

If available provide more details of the SDF application among the study subjects. Was it applied by the same clinic/person? was a similar size area treated?

All SDF treatments and oral examinations were performed by a single clinician (YC).

All areas treated were similar; since patients were older than 5 and under continuous care at our clinic, they had small lesions into enamel and dentin, confined to one dental surface only. Only one tooth was treated at that visit and sampled as described in the methods (sampling also the contralateral tooth, and using a similar amount of SDF (never more than 1 drop). We note a previous publication by the member of our research team who provided treatment on the average amount of F and Ag in a single drop: an average (SD) drop measuring 32.5 mL (microliters) would have approximately 1.64 (0.04) to 1.76 (0.05) mg of fluoride, and 8.08 (0.13) to 8.71 (0.38) mg of silver. We have added this to the manuscript.

Discuss the limitations of the study including the small sample size, problems of 16S sRNA amplification bias.

We have added additional information (there is a similar comment regarding sample size from the other reviewer) to the discussions/limitations, specifically: 16S rRNA gene amplicon sequencing captures broad shifts in community diversity over time, but with limited resolution and lower sensitivity compared to metagenomic shotgun sequencing. Our use of the PICRUSt package to predict metagenome functional content from 16S rRNA extends our analysis. Additionally, bias may have been introduced due to varying 16S rRNA PCR amplification frequencies. Sequencing errors due to PCR amplification were mitigated by removing mismatches to primers, and denoising and trimming reads with low quality scores during sequencing analyses.

Change sugar throughout the text to carbohydrate.

These have been changed

Reviewer #2: This manuscript examines the response of oral caries flora to treatment with silver diamine fluoride (SDF), a therapy used for non-surgical caries management in the US. Multiple in vitro studies have shown that SDF inhibits bacterial cell growth through interaction with bacterial cell membranes and enzymes. A primary goal of this study is to examine the efficacy of SDF in a cohort of 20 children 6-13 years of age, and identify the oral bacteria that contribute to a non-responder phenotype, in which the bacteria are resistant to or survive treatment with SDF and have low treatment efficacy. The primary limitations of the study include the small sample size and study design.

Comments:

1. The sample size is small, with 5 children in each of 4 separate treatment groups. The authors do clearly state that this is a pilot study, but do not sufficiently emphasize this limitation when drawing their conclusions in the results and discussion.

We agree with the reviewer regarding the limitation of our study. We have added few lines in the results and discussion of the manuscript to address this issue., specifically in the picrust results and in the concluding paragraph of the discussion. This perspective is both from the microbiologic and epidemiologic.

2. Is SDF bacteriostatic or bacteriocidal? This is a key, but unaddressed point, in the paper. Why would a bacteriostatic agent be an effective therapeutic?

SDF is bactericidal, we have noted this in the introduction to the paper and provided a citation which states that in a review of studies on the effect of SDF on cariogenic bacteria, specifically Streptococcus mutans (Zhao et al, 2018; IDJ DOI: 10.1111/idj.12320). Others include Abdullah et al, 2020; https://doi.org/10.1371/journal.pone.0241519 & Burgers et al, 2009; https://doi.org/10.1016/j.archoralbio.2009.03.004.

3. In group 3, the authors sample plaque from surface of a tooth with open caries within 10 minutes after application of SDF. A reasonable rationale for this short time period between SDF application and plaque sampling is needed. An important aspect that the authors do not consider is viability of bacteria on the tooth surface. Taxonomic identification by 166 rRNA amplicon sequencing relies only on the presence of bacterial genomic DNA. It does not access viability of bacteria at that site.

We admit that this is a limitation. As this was a pilot study, access to subjects and corresponding samples was limited to a single observation. As a result, we elected to investigate the immediate effects of therapy. Though we are aware that identifying DNA of present bacteria does not elucidate their viability, we wanted to study if there was an immediate measurable effect in order to better plan for future studies. The follow-up, full study to this pilot (currently underway) will collect longitudinal data with variable rates of time following application of SDF. We have included this as part of a larger discussion section on the sample size and timing limitations of the study.

4. The accepted term is 16S rRNA amplicon sequencing.

We have made the changes in the manuscript.

5. The print (text figure labels) in Figures 1-3 is small and will be very difficult to read when the figures are reduced for publication.

Thank you – we will ensure that if accepted for publication this is reviewed in the proofing/typsetting stage. Additionally, in our revision following with PLOS One style guidelines, our figure labels are now embedded within the manuscript.

6. It is not clear what Fig 3 (PiCrust) contributes to the paper. None of the identified pathways are statistically significant and no meaningful conclusions can be drawn from this analysis.

Thank you for your comment. Although the data was not statistically significant due to the small sample size, nevertheless we saw a trend in the plots, specifically higher in non-responders and amongst those that are involved in caries. Additionally, Fig 3 compares the role of bacteria in some of the most important metabolic pathways of bacteria. Future studies aiming to study these pathways with a larger sample size may reveal statistically significant data. As we are actively collecting data as part of a new longitudinal study to expand on this pilot, we feel it is important to note these results.

7. The identification of Granulicatella, Leptotrrichia, and Tannerella in the non -responders is interesting, with a plausible biological basis of their roles in caries presented in the discussion.

Thank you for your helpful comments and for your review, it is sincerely appreciated.

Attachment

Submitted filename: Response to Reviewers v3.docx

Decision Letter 1

Ping Xu

25 Jan 2021

Microbial population shift and metabolic characterization of silver diamine fluoride treatment failure on dental caries

PONE-D-20-34812R1

Dear Dr. Ryan Richard Ruff,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Ping Xu

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: (No Response)

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: (No Response)

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: (No Response)

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: (No Response)

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: I have no further comments, the authors did address all my listed concerns. Thank you for being responsive to my suggestions.

Reviewer #2: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Acceptance letter

Ping Xu

24 Feb 2021

PONE-D-20-34812R1

Microbial population shift and metabolic characterization of Silver Diamine Fluoride treatment failure on dental caries

Dear Dr. Ruff:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Professor Ping Xu

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    Attachment

    Submitted filename: Response to Reviewers v3.docx

    Data Availability Statement

    BIOM files generated with QIIME2 and scripts used to generate figures are available on GitHub (https://github.com/mariaasierra/Dental_Caries).


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES